Skip to main content
. 2022 Nov 10;13:953210. doi: 10.3389/fimmu.2022.953210

Figure 11.

Figure 11

Forest plot depicts a comparison of the incidence of late onset CMV disease among LT recipients undergoing antiviral prophylaxis and preemptive therapy.